Month: October 2022

Singh, Rahul; Kumar, Ravinder; Pandrala, Mallesh; Kaur, Parleen; Gupta, Saloni; Tailor, Dhanir; Malhotra, Sanjay V.; Salunke, Deepak B. published the artcile< Facile synthesis of C6-substituted benz[4,5]imidazo[1,2-a]quinoxaline derivatives and their anticancer evaluation>, Computed Properties of 112-63-0, the main research area is benzimidazoquinoxaline preparation anticancer activity; MDA-MB-468; NCI-60; anticancer agents; benzimidazole; breast cancer cell line; heterocycles; quinoxaline.

On the basis of the promising anticancer potential of imidazoquinoxaline as well as the structurally similar imidazoquinoline-derived scaffold, a set of C6-substituted benzimidazo[1,2-a]quinoxaline derivatives I (R = OMe, benzylaminyl, 1H-1,3-benzodiazol-1-yl, etc.) was prepared via two novel synthetic routes using com. available starting materials, with good to excellent yields and evaluated for their anticancer activity against the NCI-60 cancer cell lines. The one-dose (10μM) anticancer screening of the synthesized compounds I in the NCI-60 cell line panel revealed that the substituents have a significant role in the activity. In particular, compounds I (R = 1H-indol-1-yl, 1H-imidazol-1-yl, 1H-1,3-benzodiazol-1-yl) derivatives showed significant activity against the triple-neg. breast cancer cell line, MDA-MB-468. The lead compounds also exhibited notable IC50 values against another breast cancer cell line, MCF-7. Furthermore, synthesized compounds I were relatively nontoxic to normal cell lines: HEK293 (human embryonic kidney cell line) and MCF12A (nontumorigenic human breast epithelial cell line). The IC50 values against healthy cells were at least 5- to 11-fold higher, offering a new class of heterocycles that can be further developed as promising therapeutics for cancer treatment.

Archiv der Pharmazie (Weinheim, Germany) published new progress about Amines Role: RCT (Reactant), RACT (Reactant or Reagent). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Computed Properties of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Candiota, Ana Paula; Arus, Carles published the artcile< Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives>, Quality Control of 112-63-0, the main research area is PD1 host immune system glioblastoma magnetic resonance spectroscopy imaging; cancer immune cycle; glioblastoma; host immune system; imaging biomarker; immunotherapy; magnetic resonance spectroscopic imaging; metabolomics.

This hypothesis proposal addresses three major questions: (1) Why do we need imaging biomarkers for assessing the efficacy of immune system participation in glioblastoma therapy response (2) Why are they not available yet and (3) How can we produce them. We summarize the literature data supporting the claim that the immune system is behind the efficacy of most successful glioblastoma therapies but, unfortunately, there are no current short-term imaging biomarkers of its activity. We also discuss how using an immunocompetent murine model of glioblastoma, allowing the cure of mice and the generation of immune memory, provides a suitable framework for glioblastoma therapy response biomarker studies. Both magnetic resonance imaging and magnetic resonance-based metabolomic data (i.e., magnetic resonance spectroscopic imaging) can provide non-invasive assessments of such a system. A predictor based in nosol. images, generated from magnetic resonance spectroscopic imaging analyses and their oscillatory patterns, should be translational to clinics. We also review hurdles that may explain why such an oscillatory biomarker was not reported in previous imaging glioblastoma work. Single shot explorations that neglect short-term oscillatory behavior derived from immune system attack on tumors may mislead actual response extent detection. Finally, we consider improvements required to properly predict immune system-mediated early response (1-2 wk) to therapy. The sensible use of improved biomarkers may enable translatable evidence-based therapeutic protocols, with the possibility of extending preclin. results to human patients.

Metabolites published new progress about Behavior (short-term oscillatory). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Quality Control of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

K. Pagire, Santosh; Kumagai, Naoya; Shibasaki, Masakatsu published the artcile< Highly Enantio- and Diastereoselective Synthesis of 1,2,3-Trisubstituted Cyclopropanes from α,β-Unsaturated Amides and Stabilized Sulfur Ylides Catalyzed by a Chiral Copper(I) Complex>, COA of Formula: C19H34O2, the main research area is cyclopropane preparation enantioselective diastereoselective; amide sulfur ylide cyclization copper catalyst.

Herein, the previously elusive catalytic asym. cyclopropanation of α,β-unsaturated amides, e.g., (E)-3-(but-2-enoyl)oxazolidin-2-one with stabilized sulfur ylides RC(O)CH=S(Me)2 has been efficiently accomplished utilizing a chiral Cu(I) complex. This Lewis acid catalytic system effectively converts a wide range of electron-deficient alkenes into the corresponding 1,2,3-trisubstituted cyclopropanes, e.g., I under mild reaction conditions in good to excellent yields with both high to excellent enantio- and diastereoselectivities. The resulting enantiomerically enriched cyclopropane amides can be readily diversified into promising synthetic intermediates such as β-aminocyclopropanecarboxylic acids with the facile recovery of the 7-azaindoline auxiliary without influencing the optical purity of the cyclopropane unit, which highlights the synthetic efficacy of this catalytic approach.

ACS Catalysis published new progress about Carboxylic acids Role: FMU (Formation, Unclassified), FORM (Formation, Nonpreparative). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, COA of Formula: C19H34O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Unger, Katrin; Salzmann, Paul; Masciullo, Cecilia; Cecchini, Marco; Koller, Georg; Coclite, Anna Maria published the artcile< Novel Light-Responsive Biocompatible Hydrogels Produced by Initiated Chemical Vapor Deposition>, Application of C9H3F5O2, the main research area is chem vapor deposition biocompatible hydrogel light swelling azobenzene; biocompatibility; hydrogels; iCVD; photoresponse; smart materials.

A novel multiresponsive hydrogel has been synthesized by initiated chem. vapor deposition (iCVD). Hydrogels are known for their dynamic swelling response to aqueous environments. A chem. functionalization of the hydrogel surface was performed to add other stimuli-responsive functionalities and obtain a smart material that responds to two stimuli: light irradiation and exposure to aqueous environment. Modifying the hydrogel surface with solution-based methods is often problematic because of the damages caused by the permeation of solvents in the hydrogel. This issue is completely bypassed by the use of solvent-free techniques. Cross-linked polymers of 2-hydroxyethyl methacrylate (HEMA) were functionalized with azobenzene groups, as confirmed by IR spectroscopy and XPS. Through photoisomerization of the azobenzene, the polarity within the hydrogel is modified and as a consequence the affinity to water. Light irradiation modifies the degree of swelling within thin hydrogel films from 13% before exposure to UV light to 25% after exposure. The possibility of controlling the degree and rate of swelling by light irradiation was never reported before on these time scales and can have exceptional implications for light-induced drug delivery or light-controlled microfluidic systems. The light-responsive hydrogels showed also biocompatibility, which makes them suitable for a great variety of applications as biomaterials.

ACS Applied Materials & Interfaces published new progress about Biocompatibility. 71195-85-2 belongs to class esters-buliding-blocks, and the molecular formula is C9H3F5O2, Application of C9H3F5O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Owa, Takashi published the artcile< Chemistry and biology of a series of antitumor sulfonamides: exploiting transcriptomic and quantitative proteomic analyses for exploring drug gable chemical space>, Electric Literature of 112-63-0, the main research area is cancer antitumor sulfonamide derivative SAR preparation.

Sulfolnamide-focused compound libraries have been synthesized in our laboratories for biol. evaluation using antitumor phenotypic screens such as cancer cell proliferation assay, flow cytometric cell cycle anal., and rat aorta tube formation assay. Among thousands of sulfonamide compounds evaluated, E7010 (a microtubule depolymerizing agent), E7070 (a G1 phase cell cycle inhibitor), and E7820 (an antiangiogenesis agent) have progressed to clin. trials, thereby demonstrating some objective responses in cancer patients so far. The sequential discovery of these drug candidates allowed us to carry out a research approach of forward chem. genetics, in which phenotypically bioactive compounds are selected from a large collection of small mols. and then utilized for understanding the functions of their protein partners and relevant biol. pathways via target identification. This paper describes our attempt using oligonucleotide microarray and quant. proteomic analyses not only for identifying drug targets and downstream pathways applicable to biomarkers but also for exploring drug gable chem. space in medicinal chem. research.

Yuki Gosei Kagaku Kyokaishi published new progress about Antibacterial agents. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Electric Literature of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Singh, Santosh Kumar; Dey, Swapan; Schneider, Manfred P.; Nandi, Sukhendu published the artcile< D-Mannitol based surfactants for cosmetic and food applications and hydrogels to produce stabilized Ag nanoparticles>, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is mannitol surfactant silver nanoparticle hydrogel cosmetic food application.

A series of mannitol based amphiphiles were synthesized based mainly on renewable resources. All these amphiphiles are surfactants with excellent foaming abilities and low CMC values. Their surface-active properties (foaming and emulsifying) with the variation of hydrocarbon chains have been thoroughly investigated. Notably, they all produce very stable hydrogels. The thermal stability of the hydrogel is strongly influenced by the length of the hydrocarbon chain of the lipophilic part of the mols. Different spectroscopic and microscopic techniques were used to study the morphol. of the hydrogels and the driving force leading to hydrogel formation. Besides that, such hydrogel was used as a scaffold to stabilize in situ formed silver nanoparticles (Ag NPs) through their capping action. Such synthesized Ag NPs have a narrow size distribution with a mean population of around 13.5 nm, as confirmed by a high-resolution transmission electron microscopy study.

New Journal of Chemistry published new progress about Amphiphiles. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Zhou, Jing; Sun, Caoyu; Dong, Xu; Wang, Hui published the artcile< A novel miR-338-3p/SLC1A5 axis reprograms retinal pigment epithelium to increases its resistance to high glucose-induced cell ferroptosis>, Electric Literature of 347174-05-4, the main research area is miR3383p SLC1A5 retinal pigment epithelium high glucose cell ferroptosis; Cell ferroptosis; Diabetic retinopathy; ROS; SLC1A5; miR-338-3p.

Oxidative stress-induced cell ferroptosis occurs during the pathogenesis of diabetic retinopathy (DR), but the detailed mol. mechanisms are still unclear. The present study aimed to investigate this issue. Materials and methods: The retinal pigment epithelium (RPE) was treated with high glucose (30 mM) in vitro to mimic the realistic conditions of DR progression in vivo. Cell viability was determined by MTT assay and trypan blue staining assay. Gene expressions were examined by Real-Time qPCR and Western Blot anal. FCM was used to detect cell apoptosis and ROS generation. Dual-luciferase reporter gene system assay was used to verify the targeting sites. High glucose increased reactive oxygen species (ROS) levels, promoted cell ferroptosis, and suppressed cell proliferation and viability in RPE, which were reversed by co-treating cells with both a ferroptosis inhibitor ferrostatin-1 and an ROS scavenger, N-acetyl-L-Cysteine (NAC). In addition, we screened out a miR-338-3p/ASCT2 (SLC1A5) axis that played an important role in this process. Mechanistically, miR-338-3p targeted the 3 untranslated regions (3UTR) of SLC1A5 for its inhibition and degradation, and high glucose downregulated SLC1A5 by upregulating miR-338-3p in RPE cells. Next, the miR-338-3p inhibitor and SLC1A5 overexpression vectors were delivered into the RPE cells, and the following gain- and loss-of-function experiments validated that both miR-338-3p ablation and SLC1A5 upregulation abrogated the regulating effects of high glucose on cell proliferation, viability, ferroptosis and ROS production in RPE cells. Collectively, data in the present study indicated that targeting the miR-338-3p/SLC1A5 axis could block high glucose-induced ferroptosis in RPE cells.

Journal of Molecular Histology published new progress about 3′-Untranslated region Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 347174-05-4 belongs to class esters-buliding-blocks, and the molecular formula is C15H22N2O2, Electric Literature of 347174-05-4.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Feng, Yaqing; Zhang, Weihong; Chen, Ligong; Froelich, J.; Meretter, K.; Sauter, F. published the artcile< Synthesis and x-ray structure of new spiro-imidazo[2,1-b]thiazole>, COA of Formula: C19H34O2, the main research area is spiro imidazothiazole preparation crystal structure; mol structure spiro imidazothiazole.

Spiro[5.5]undecan-3-one was converted to 4,7-dihydrospiro[benzo[d]thiazole-6(5H),1′-cyclohexan]-2-amine, which is condensed with bromomethyl (halo)phenyl ketones and cyclized to yield the title compounds I (R = H, Cl, Br). The x-ray crystallog. anal. of I (R = Cl) reveals that the formation of I proceeds via 3-substituted spiro-iminothiazoles.

Journal of Heterocyclic Chemistry published new progress about Crystal structure. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, COA of Formula: C19H34O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Lategan, Thomas W.; Wang, Laurene; Sprague, Tiffany N.; Rousseau, Franck S. published the artcile< Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam (Monomethyl Fumarate) or Tecfidera (Dimethyl Fumarate)>, Synthetic Route of 112-63-0, the main research area is bafiertam bioavailability pharmacokinetics.

Tecfidera (di-Me fumarate [DMF]) is an approved product for the treatment of relapsing forms of multiple sclerosis. Monomethyl fumarate (MMF) is the only active metabolite of DMF and is responsible for its therapeutic efficacy. Objective: The objective of this study was to determine whether two Bafiertam capsules each containing 95 mg of MMF is bioequivalent to one Tecfidera capsule containing 240 mg of DMF, a prodrug of MMF. This was a single-dose, open-label, randomized, two-way crossover study evaluating two treatments over two periods with a washout interval between treatments. Fifty healthy subjects were randomized to receive a single dose of the test drug MMF 190 mg as 2 x 95 mg delayed-release capsules or the reference drug DMF 240 mg as a 1 x 240-mg delayed-release capsule. Blood samples were obtained prior to dosing and at prespecified time points through 24 h post-dose to determine plasma concentrations of MMF. The pharmacokinetic parameters of MMF were calculated including maximum observed concentration, time to reach maximum observed concentration, apparent half-life of the drug in plasma, AUC0-t which is the area under the plasma concentration-time curve (AUC) from time zero (dosing time) to the last time point, t, with measurable analyte concentration, and AUC0-inf, which is AUC0-t plus the extrapolated AUC from time t to infinity. The geometric least-squares mean ratios (90% confidence interval) of the test drug MMF vs the reference drug DMF were 96.80% (92.18-101.64), 96.35% (91.81-101.12), and 104.84% (95.54-115.05) for AUC0-t, AUC0-inf, and maximum observed concentration, resp. Two capsules of Bafiertam was safe and generally well tolerated. The most common adverse event for both products was flushing, 60% and 51%, for Bafiertam and Tecfidera, resp. Conclusions: Based on the statistical anal. results of the pharmacokinetic parameters of MMF, a single oral dose of two Bafiertam DR 95 mg capsules is bioequivalent to a single oral dose of one Tecfidera DR 240 mg capsule. Clin. Trial Registration: This study was retrospectively registered with ClinicalTrials.gov (NCT04570670) on 30 Sept., 2020.

CNS Drugs published new progress about Bioavailability. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Synthetic Route of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Shao, Yuewen; Li, Yue; Sun, Kai; Zhang, Zhanming; Tian, Hongli; Gao, Guoming; Li, Qingyin; Liu, Qianhe; Liu, Qing; Hu, Xun published the artcile< Sulfated Zirconia with Different Crystal Phases for the Production of Ethyl Levulinate and 5-Hydroxymethylfurfural>, SDS of cas: 112-63-0, the main research area is ethyl levulinate sulfated zirconia crystal phase.

Distinct crystal phases of an oxide affect the configuration of surface atoms, which might further affect coordination with sulfate during sulfonation for the preparation of SO42-/MxOy type of acid catalyst. Herein, such an effect is investigated with zirconia of the tetragonal or monoclinic phase as the model catalysts. The results show that sulfonation inhibits the transformation of zirconia from the tetragonal phase to the monoclinic phase, whereas the varied phase of zirconia also affects the bonding patterns of sulfate species with zirconia in sulfonation. The sulfated zirconia of monoclinic phase contains more abundant acidic sites and more Bronsted acid sites than that of sulfated zirconia of tetragonal phase. Consequently, the sulfated zirconia of monoclinic phase is more active than the sulfated zirconia of tetragonal phase for the conversion of furfuryl alc. in ethanol and conversion of fructose in DMSO, achieving the yield of Et levulinate of 96.4% and a high yield of 5-hydroxymethylfurfural. The sulfated zirconia is not stable in protic solvent due to the leaching of sulfur species and the change in configurations of the sulfate species and the zirconium species, but in the aprotic solvent, they show good stability and recyclability.

Energy Technology (Weinheim, Germany) published new progress about Crystals. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics